Oct 20, 2026 08:00AM
Sep 16, 2026 09:33AM
Sep 14, 2026 07:34AM
Aug 10, 2026 04:26AM
Aug 6, 2026 04:08PM
May 12, 2026 04:08PM
May 7, 2026 08:00AM Solid Biosciences begins phase 3 trial for Duchenne therapy SGT-003
May 7, 2026 08:00AM
Apr 30, 2026 08:00AM
Apr 28, 2026 08:02AM
Apr 28, 2026 08:00AM
Mar 19, 2026 04:12PM
Mar 11, 2026 01:01PM
Mar 11, 2026 01:01PM Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
Mar 6, 2026 08:31AM
Mar 6, 2026 08:31AM
Mar 6, 2026 08:30AM
Mar 6, 2026 08:30AM
Feb 10, 2026 04:47AM
Feb 9, 2026 08:00AM
Feb 9, 2026 08:00AM Solid Biosciences Announces Positive Feedback from Type C Meeting with FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy
Jan 13, 2026 04:15PM
Jan 13, 2026 04:15PM
Jan 12, 2026 04:15PM
Jan 12, 2026 04:15PM
Jan 12, 2026 08:05AM
Jan 12, 2026 08:05AM
Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
Dec 17, 2025 05:31AM
Dec 16, 2025 04:51PM
Dec 16, 2025 04:51PM
Dec 8, 2025 08:00AM
Dec 1, 2025 08:04AM
Dec 1, 2025 08:00AM
Nov 17, 2025 08:04AM Solid Biosciences licenses capsid technology to Andelyn Biosciences
Nov 17, 2025 08:00AM
Nov 6, 2025 08:04AM
Nov 6, 2025 08:00AM
Nov 3, 2025 04:05PM
Oct 24, 2025 08:29AM
Oct 1, 2025 08:00AM
Sep 25, 2025 08:00AM Solid Biosciences to Present at 2025 Neuromuscular Study Group Annual Scientific Meeting
Sep 23, 2025 08:00AM
Sep 23, 2025 08:00AM
Sep 12, 2025 04:10AM
Aug 14, 2025 04:22AM
Aug 12, 2025 04:07PM
Jul 23, 2025 08:00AM
Jul 23, 2025 08:00AM Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Jul 17, 2025 04:50AM

335,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All